39.84 1.45 (3.78%)

29.95% Fall from 52W High

795.8K XNAS Volume

XNAS 27 Mar, 2025 5:30 PM (EDT)

MoonLake Immunotherapeutics - Ordinary Shares - Class A quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history